A Study to Investigate Cabotegravir for Neonates Exposed to HIV-1
Status:
NOT_YET_RECRUITING
Trial end date:
2029-10-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics (PK) of cabotegravir in neonates exposed to human immunodeficiency virus (HIV)-1.